Hennion & Walsh Asset Management, Inc. Arvinas, Inc. Transaction History
Hennion & Walsh Asset Management, Inc.
- $2.15 Billion
- Q1 2025
A detailed history of Hennion & Walsh Asset Management, Inc. transactions in Arvinas, Inc. stock. As of the latest transaction made, Hennion & Walsh Asset Management, Inc. holds 61,877 shares of ARVN stock, worth $453,558. This represents 0.02% of its overall portfolio holdings.
Number of Shares
61,877
Previous 63,477
2.52%
Holding current value
$453,558
Previous $1.22 Million
61.43%
% of portfolio
0.02%
Previous 0.06%
Shares
6 transactions
Others Institutions Holding ARVN
# of Institutions
245Shares Held
62.5MCall Options Held
2.65MPut Options Held
1.1M-
Vanguard Group Inc Valley Forge, PA8.36MShares$61.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.26MShares$45.9 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il3.88MShares$28.4 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.83MShares$28 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY3.33MShares$24.4 Million0.38% of portfolio
About ARVINAS, INC.
- Ticker ARVN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,205,300
- Market Cap $390M
- Description
- Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor ...